United Therapeutics is a biotechnology company that develops and markets therapies for pulmonary arterial hypertension and other rare diseases, and is pursuing organ-manufacturing and xenotransplantation.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Bridgewater | 55 | Added +13% | 125,394 | $67,949,755 | 0.3% |
| Ancora | 42 | Holds (flat) | 10 | $5,419 | 0.0% |
| Steve Cohen / Point72 | 75 | Trimmed -12% | 176,950 | $95,887,436 | 0.1% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-08-22 | Trump, Donald J President | BUY | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.